Of note, 77.1% of the NAT specimens showed moderate-to-strong FAS expression; however, only 35.4% of NSCLC tissue specimens presented moderate-to-strong FAS expression (Fig. 2d). Here, BRD2 is linked to non-small cell lung carcinoma.